OQS
ANGO icon

Occudo Quantitative Strategies’s AngioDynamics ANGO Stock Holding History

Occudo Quantitative Strategies’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-31,920
Closed -$187K – 744
2024
Q1 		$187K Sell
31,920
-20,822
-39% -$124K 0.03% 605
2023
Q4 		$413K Sell
52,742
-19,065
-27% -$132K 0.06% 448
2023
Q3 		$525K Buy
71,807
+27,676
+63% +$230K 0.07% 473
2023
Q2 		$460K Buy
+44,131
New +$425K 0.05% 584

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Occudo Quantitative Strategies's ANGO Position: Q2 2024 in Review

Occudo Quantitative Strategies sold out of AngioDynamics (ANGO) in Q2 2024, closing a stake of 31,920 shares — an estimated $187K sold.

Occudo Quantitative Strategies first reported a position in ANGO in Q2 2023 and held it in 4 quarters. The position peaked at $525K in Q3 2023. 139 funds tracked by Wall St. Rank hold ANGO as of Q2 2024.

  • Occudo Quantitative Strategies reported no remaining AngioDynamics position as of Q2 2024 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 31,920 AngioDynamics shares in Q2 2024, an estimated $187K.
  • Occudo Quantitative Strategies first reported a position in AngioDynamics in Q2 2023 and held it in 4 quarters.
  • Occudo Quantitative Strategies's AngioDynamics position peaked at $525K in Q3 2023.
  • 139 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2024.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.